Abstract
DURING the growth of certain transplanted tumours considerable hyperactivity of the reticulo-endothelial system is observed.1 Similar alterations are also found in the first stage of experimental infections2, suggesting that the host response to foreign tissue and some infectious agents is closely related. Agents such as endotoxins, zymosan, products of the tubercle bacillus, and Bacillus Calmette-Guérin infection which enhance the activity of the reticulo-endothelial system3 and the capacity for antibody production4 also increase natural resistance to infection5. In light of these observations, we have attempted to alter the growth and lethality of various experimental tumours by agents known to possess the common property of stimulating the phagocytic capacity of the reticulo-endothelial system. One such agent, zymosan, has been demonstrated to increase significantly the regression rate of the mouse tumour, sarcoma 180 (S-180), under certain conditions6. The present report deals with the course of three transplantable tumours, S-180, carcinoma 755 (Ca 755), and Ehrlich ascites, in mice infected with Bacillus Calmette-Guérin.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung
Nature Communications Open Access 04 October 2023
-
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
British Journal of Cancer Open Access 15 July 2023
-
BCG-induced trained immunity: history, mechanisms and potential applications
Journal of Translational Medicine Open Access 10 February 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Biozzi, G., Stiffel, C., Halpern, B. N., and Mouton, D., Ann. Inst. Pasteur, 94, 681 (1958). Stern, K., and Duwelius, A., Proc. Amer. Assoc. Cancer Res., 2, 348 (1958). Old, L. J., Clarke, D. A., and Goldsmith, M., Proc. Amer. Assoc. Cancer. Res., 3, 49 (1959).
Biozzi, G., Halpern, B. N., Benacerraf, B., and Stiffel, C., “Physiopathology of the Reticulo-Endothelial System”, 204 (Blackwells Scientific Publications, Oxford, 1957). Boehme, D., and Dubos, R. J., J. Exp. Med., 107, 523 (1958).
Biozzi, G., Benacerraf, B., and Halpern, B. N., Brit. J. Exp. Path., 36, 226 (1955). Benacerraf, B., and Sebestyen, M., Fed. Proc., 16, 860 (1957). Biozzi, G., Benacerraf, B., Grumbach, F., Halpern, B. N., Levaditi, J., and Rist, N., Ann. Inst. Pasteur, 87, 291 (1954).
Johnson, A. G., Gaines, S., and Landy, M., J. Exp. Med., 103, 225 (1956). Cutler, J. L., Fed. Proc., 18, 33 (1959). Halpern, B. N., Biozzi, G., Stiffel, C., and Mouton, D., C. R. Soc. Biol., 151, 758 (1958).
Rowley, D., Lancet, i, 232 (1955). Dubos, R. J., and Schaedler, R., J. Exp. Med., 106, 703 (1957).
Bradner, W. T., Clarke, D. A., and Stock, C. C., Cancer Res., 18, 347 (1958).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
OLD, L., CLARKE, D. & BENACERRAF, B. Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse. Nature 184, 291–292 (1959). https://doi.org/10.1038/184291a0
Issue Date:
DOI: https://doi.org/10.1038/184291a0
This article is cited by
-
BCG-induced trained immunity: history, mechanisms and potential applications
Journal of Translational Medicine (2023)
-
Mycobacterium tuberculosis as teacher
Nature Microbiology (2023)
-
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
British Journal of Cancer (2023)
-
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung
Nature Communications (2023)
-
Cancer vaccines: the next immunotherapy frontier
Nature Cancer (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.